
Rangaprasad Sarangarajan
@rangasarangan
R&D Innovation & Drug Development #Metabolomics #Multiomics
ID: 1093849513893261312
http://www.metabolon.com 08-02-2019 12:30:21
130 Tweet
14 Followers
50 Following

Delighted to be in London today to hear Matt Brown announce our (Metabolon, Inc.)’s collaboration with Genomics England to better understand rare diseases. Excited to get this research underway! #GERS2023







NEW BLOG POST from our Chief Scientific Officer, Rangaprasad Sarangarajan: bit.ly/3HUzFP8. It delves into the intersection of #metabolomics & population-scale #metabogenomics, providing insights into the dynamic relationship btwn an individual's #metabolome & their #genetic makeup





Unlock the secrets of #metabolomics & discover why our extensive library coverage is a game-changer from our Chief Scientific Officer, Rangaprasad Sarangarajan in his latest blog post, “Why Metabolomics and Metabolon’s Library Coverage: A Compelling Rationale,” bit.ly/3POhfUX.



.Vivek Subbiah, MD chaired the Plenary Session on "AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, and Improving Trial Design" this morning at #AACR24.



In our newest blog, Rangaprasad Sarangarajan explores the synergistic relationship between #metabolomics and #epigenomics within the context of #multiomics research, essential for advancing #precisionmedicine and #biomarkerdiscovery: bit.ly/3JU1IPM #omics #phenotype

.Dr. Rob Winn talks about the great work that has been done to move the needle regarding closing the #CancerDisparities gap and the importance of the work that needs to be done so cancer care can be accessible to everyone. VCU Massey Comprehensive Cancer Center #CancerDisparitiesReport


